Profile
Sector:
Basic MaterialsIndustry:
Specialty ChemicalsCountry:
United StatesIPO:
17 May 2019Website:
http://www.avantorsciences.comNext earnings report:
26 July 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:00:01 GMTDividend
Analysts recommendations
Institutional Ownership
AVTR Latest News
Avantor, Inc. AVTR recently released two innovative products aimed at revolutionizing the gene therapy harvest process. J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease are designed to enhance efficiency, reduce environmental impact, improve operational outcomes and preserve the integrity of viral particles.
Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at Scale RADNOR, Pa. , July 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the launch of two innovative products that together sustainably optimize the gene therapy harvest process: J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease.
RADNOR, Pa. , June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2024 financial results before the market opens on Friday, July 26, and will hold a conference call on the same day at 8:00 a.m.
Achieves 2025 Greenhouse Gas Emission reduction goals two years ahead of schedule RADNOR, Pa., June 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, released its 2024 Sustainability Report today.
RADNOR, Pa. , May 29, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Fla.
Although Avantor (AVTR) has remained steady in its end markets, it has reported a generally weak performance in the first quarter.
Avantor (AVTR) is experiencing positive changes in earnings estimates and has a strong Zacks Earnings ESP as earnings season approaches.
Investors who are interested in Medical Services stocks may have come across both Elevance Health (ELV) and Avantor, Inc. (AVTR). The question now is, which of these two stocks is more appealing to value investors?
Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
What type of business is Avantor?
Avantor, Inc. is an American company specializing in the production of materials and equipment for the biopharmaceutical and healthcare industries. It has a history dating back to 1904 and was officially registered in its current form in 2017 in the state of Delaware. The portfolio of products and services includes: - Materials and consumables, including chemicals and reagents, laboratory products and consumables, specialized silicone materials, customized excipients, individual disposable assemblies, and more. - Equipment and instruments, such as filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low temperature freezers, biological safety cabinets, and materials for critical environments. - Services and specialized procurement, including laboratory and manufacturing services, procurement services, as well as services for the development of biopharmaceutical materials.
What sector is Avantor in?
Avantor is in the Basic Materials sector
What industry is Avantor in?
Avantor is in the Specialty Chemicals industry
What country is Avantor from?
Avantor is headquartered in United States
When did Avantor go public?
Avantor initial public offering (IPO) was on 17 May 2019
What is Avantor website?
https://www.avantorsciences.com
Is Avantor in the S&P 500?
No, Avantor is not included in the S&P 500 index
Is Avantor in the NASDAQ 100?
No, Avantor is not included in the NASDAQ 100 index
Is Avantor in the Dow Jones?
No, Avantor is not included in the Dow Jones index
When does Avantor report earnings?
The next expected earnings date for Avantor is 26 July 2024